AIIMS and Medtronic Collaborate to Establish Surgical Robotics Training Center in India

04 May 2023 | Thursday | News

Training partnership aims to expand access to robotic-assisted surgery in India

All India Institute of Medical Sciences (AIIMS) New Delhi and India Medtronic, a wholly owned subsidiary of Ireland-based Medtronic plc, has announced the opening of a state-of-the-art surgical robotics training centre at AIIMS, New Delhi.

The centre will provide surgeons with best-in-class training in robotic-assisted surgery. It is the first such centre at AIIMS utilising Medtronic’s Hugo robotic-assisted surgery (RAS) system, which was first introduced in India in September 2021.

RAS is an emerging medical technology that can help standardise surgical procedures and enable surgeons in performing complex surgeries. The training centre will offer a broad spectrum of training to enhance the knowledge and skill set in RAS, ranging from basic skills training to procedural training to more advanced and specialized areas in soft-tissue surgery. The training will help impart procedural knowledge skills using surgical robotics among surgeons, fellows, and residents from across the country.

The Hugo robotic-assisted surgery (RAS) system is not cleared or approved in all markets. Regulatory requirements of individual countries and regions will determine approval, clearance, or market availability. In the US, the Hugo RAS system is an investigational device not for sale.

“Medtronic’s partnership with AIIMS is a cornerstone of our commitment to make the benefits of RAS available to more patients in India. Together, we will make training and education on the latest technology more accessible and enhance the skill sets of both current and the next generation of surgeons,” said Michael Blackwell, Vice President & Managing Director, Medtronic India.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close